186 related articles for article (PubMed ID: 18030471)
1. Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.
Ma R; Song G; You W; Yu L; Su W; Liao M; Zhang Y; Huang L; Zhang X; Yu T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):559-68. PubMed ID: 18030471
[TBL] [Abstract][Full Text] [Related]
2. [Apoptosis of human nasopharyngeal carcinoma CNE-2Z cells induced by tubeimoside I].
Weng XY; Ma RD; Yu LJ
Ai Zheng; 2003 Aug; 22(8):806-11. PubMed ID: 12917024
[TBL] [Abstract][Full Text] [Related]
3. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells.
Zhang Y; Xu X; He P
Mol Med Rep; 2011; 4(1):25-9. PubMed ID: 21461558
[TBL] [Abstract][Full Text] [Related]
4. Role of mitochondria and mitochondrial cytochrome c in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line.
Wang F; Ma R; Yu L
Cancer Chemother Pharmacol; 2006 Feb; 57(3):389-99. PubMed ID: 16172906
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Liu G; Kong W; Gao R; Su J
Mol Med Rep; 2018 Mar; 17(3):4327-4336. PubMed ID: 29363720
[TBL] [Abstract][Full Text] [Related]
6. Tubeimoside-1 exerts cytotoxicity in HeLa cells through mitochondrial dysfunction and endoplasmic reticulum stress pathways.
Xu Y; Chiu JF; He QY; Chen F
J Proteome Res; 2009 Mar; 8(3):1585-93. PubMed ID: 19215086
[TBL] [Abstract][Full Text] [Related]
7. Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway.
Hao W; Wang S; Zhou Z
Int J Clin Exp Pathol; 2015; 8(10):12075-83. PubMed ID: 26722392
[TBL] [Abstract][Full Text] [Related]
8. Tubeimoside‑1 induces apoptosis in human glioma U251 cells by suppressing PI3K/Akt‑mediated signaling pathways.
Cao LJ; Xie HT; Chu ZX; Ma Y; Wang MM; Shi Z
Mol Med Rep; 2020 Aug; 22(2):1527-1535. PubMed ID: 32627020
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway.
Huang P; Yu C; Liu XQ; Ding YB; Wang YX; He JL
Int J Mol Med; 2011 Oct; 28(4):579-87. PubMed ID: 21687933
[TBL] [Abstract][Full Text] [Related]
10. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
[TBL] [Abstract][Full Text] [Related]
11. Tubeimoside-1, a triterpenoid saponin, induces cytoprotective autophagy in human breast cancer cells in vitro via Akt-mediated pathway.
Jiang SL; Guan YD; Chen XS; Ge P; Wang XL; Lao YZ; Xiao SS; Zhang Y; Yang JM; Xu XJ; Cao DS; Cheng Y
Acta Pharmacol Sin; 2019 Jul; 40(7):919-928. PubMed ID: 30315250
[TBL] [Abstract][Full Text] [Related]
12. Multiple pathways were involved in tubeimoside-1-induced cytotoxicity of HeLa cells.
Xu Y; Ching YP; Zhou Y; Chiu JF; Chen F; He QY
J Proteomics; 2011 Dec; 75(2):491-501. PubMed ID: 21903181
[TBL] [Abstract][Full Text] [Related]
13. Potent anti-tumor activity and low toxicity of tubeimoside 1 isolated from Bolbostemma paniculatum.
Yu L; Ma R; Wang Y; Nishino H
Planta Med; 1994 Jun; 60(3):204-8. PubMed ID: 8073083
[TBL] [Abstract][Full Text] [Related]
14. Tubeimoside-1 inhibits the growth and invasion of colorectal cancer cells through the Wnt/β-catenin signaling pathway.
Bian Q; Liu P; Gu J; Song B
Int J Clin Exp Pathol; 2015; 8(10):12517-24. PubMed ID: 26722439
[TBL] [Abstract][Full Text] [Related]
15. NMK-TD-100, a novel microtubule modulating agent, blocks mitosis and induces apoptosis in HeLa cells by binding to tubulin.
Bhattacharya S; Kumar NM; Ganguli A; Tantak MP; Kumar D; Chakrabarti G
PLoS One; 2013; 8(10):e76286. PubMed ID: 24116100
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
[TBL] [Abstract][Full Text] [Related]
17. The compound millepachine and its derivatives inhibit tubulin polymerization by irreversibly binding to the colchicine-binding site in β-tubulin.
Yang J; Yan W; Yu Y; Wang Y; Yang T; Xue L; Yuan X; Long C; Liu Z; Chen X; Hu M; Zheng L; Qiu Q; Pei H; Li D; Wang F; Bai P; Wen J; Ye H; Chen L
J Biol Chem; 2018 Jun; 293(24):9461-9472. PubMed ID: 29691282
[TBL] [Abstract][Full Text] [Related]
18. Interaction of phomopsin A with porcine brain tubulin. Inhibition of tubulin polymerization and binding at a rhizoxin binding site.
Li Y; Kobayashi H; Tokiwa Y; Hashimoto Y; Iwasaki S
Biochem Pharmacol; 1992 Jan; 43(2):219-24. PubMed ID: 1739410
[TBL] [Abstract][Full Text] [Related]
19. Tubeimoside-1 induces G2/M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca²⁺ and caspase-dependent signaling pathways.
Chen WJ; Yu C; Yang Z; He JL; Yin J; Liu HZ; Liu HT; Wang YX
Int J Oncol; 2012 Feb; 40(2):535-43. PubMed ID: 21971569
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Biological Evaluation of 1-Methyl-1,4-dihydroindeno[1,2-c]pyrazole Analogues as Potential Anticancer Agents Targeting Tubulin Colchicine Binding Site.
Liu YN; Wang JJ; Ji YT; Zhao GD; Tang LQ; Zhang CM; Guo XL; Liu ZP
J Med Chem; 2016 Jun; 59(11):5341-55. PubMed ID: 27172319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
